$CRTG
CORETEC GROUP INC.

2021 Q4 Form 10-Q Financial Statement

#000143774921025057 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $274.7K $2.481M $316.4K
YoY Change 10.48% 684.09% -63.81%
% of Gross Profit
Research & Development $41.75K $192.3K $37.20K
YoY Change 39.17% 416.86% 45.17%
% of Gross Profit
Depreciation & Amortization $20.66K $20.65K $20.05K
YoY Change 2.99% 2.99% -0.99%
% of Gross Profit
Operating Expenses $316.0K $192.3K $37.20K
YoY Change 11.52% 416.86% 45.17%
Operating Profit
YoY Change
Interest Expense -$54.51K $44.08K $80.53K
YoY Change -82.28% -45.27% 95.42%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$370.5K -$2.672M -$434.1K
YoY Change -37.31% 515.51% -53.59%
Income Tax
% Of Pretax Income
Net Earnings -$370.5K -$2.672M -$434.1K
YoY Change -37.31% 515.5% -53.59%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$1.461K -$10.60K -$2.131K
COMMON SHARES
Basic Shares Outstanding 253.4M 252.3M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.053M $4.357M $23.66K
YoY Change 18141.81% 18315.64% 172.58%
Cash & Equivalents $4.053M $4.357M $23.66K
Short-Term Investments
Other Short-Term Assets $133.5K $127.6K $178.4K
YoY Change -25.82% -28.48% 103.86%
Inventory
Prepaid Expenses $133.5K $127.6K $178.4K
Receivables
Other Receivables
Total Short-Term Assets $4.187M $4.485M $202.1K
YoY Change 1970.82% 2119.57% 110.05%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill $166.0K $166.0K $166.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $16.34K $7.200K $1.260K
YoY Change -13.77% 471.43% -45.69%
Total Long-Term Assets $1.172M $1.183M $1.246M
YoY Change -5.79% -5.05% -6.14%
TOTAL ASSETS
Total Short-Term Assets $4.187M $4.485M $202.1K
Total Long-Term Assets $1.172M $1.183M $1.246M
Total Assets $5.359M $5.668M $1.448M
YoY Change 270.55% 291.34% 1.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $307.1K $311.2K $491.7K
YoY Change -23.23% -36.7% -28.78%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $69.55K
YoY Change -100.0% -100.0% -41.84%
Long-Term Debt Due $407.9K
YoY Change
Total Short-Term Liabilities $307.1K $719.2K $561.2K
YoY Change -30.62% 28.15% -83.98%
LONG-TERM LIABILITIES
Long-Term Debt $1.188M $793.1K $241.0K
YoY Change 345.43% 229.13%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.188M $793.1K $241.0K
YoY Change 345.43% 229.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $307.1K $719.2K $561.2K
Total Long-Term Liabilities $1.188M $793.1K $241.0K
Total Liabilities $1.495M $1.512M $802.2K
YoY Change 110.75% 88.52% -77.1%
SHAREHOLDERS EQUITY
Retained Earnings -$13.48M -$13.11M -$6.748M
YoY Change 83.7% 94.3% 30.8%
Common Stock $50.81K $50.46K $40.89K
YoY Change 18.85% 23.39% 191.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.864M $4.156M $646.2K
YoY Change
Total Liabilities & Shareholders Equity $5.359M $5.668M $1.448M
YoY Change 270.55% 291.34% 1.7%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$370.5K -$2.672M -$434.1K
YoY Change -37.31% 515.5% -53.59%
Depreciation, Depletion And Amortization $20.66K $20.65K $20.05K
YoY Change 2.99% 2.99% -0.99%
Cash From Operating Activities -$303.8K -$415.6K -$414.6K
YoY Change -4.53% 0.26% 933.09%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -43.92K 330.5K
YoY Change -100.0% -113.29% 2107.55%
NET CHANGE
Cash From Operating Activities -303.8K -415.6K -414.6K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 -43.92K 330.5K
Net Change In Cash -303.8K -459.6K -84.11K
YoY Change 20998.61% 446.39% 234.3%
FREE CASH FLOW
Cash From Operating Activities -$303.8K -$415.6K -$414.6K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$303.8K -$415.6K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
253363500
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
252285754
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
252285754
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213751145
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213751145
CY2021Q3 us-gaap Cash
Cash
4357144 USD
CY2020Q4 us-gaap Cash
Cash
22219 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
127600 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
179963 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
4484744 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
202182 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1010261 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1059026 USD
CY2021Q3 us-gaap Goodwill
Goodwill
166000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
166000 USD
CY2021Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
7196 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18946 USD
CY2021Q3 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1183457 USD
CY2020Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1243972 USD
CY2021Q3 us-gaap Assets
Assets
5668201 USD
CY2020Q4 us-gaap Assets
Assets
1446154 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
46580 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
311224 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
396019 USD
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
407930 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
719154 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
442599 USD
CY2021Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
793104 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
266598 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1512258 USD
CY2020Q4 us-gaap Liabilities
Liabilities
709197 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
69 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
69 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
50456 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
42750 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17216935 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8033313 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13111517 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7339175 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4155943 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
736957 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5668201 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1446154 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
192255 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37197 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
428251 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
117187 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2480697 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
316376 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5340325 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
780491 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
44077 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
80531 USD
us-gaap Interest Expense
InterestExpense
175015 USD
us-gaap Interest Expense
InterestExpense
357615 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
2717029 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
434104 USD
us-gaap Costs And Expenses
CostsAndExpenses
5943591 USD
us-gaap Costs And Expenses
CostsAndExpenses
1255293 USD
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
45124 USD
CY2020Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
45124 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1250 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2671905 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-434104 USD
us-gaap Net Income Loss
NetIncomeLoss
-5898467 USD
us-gaap Net Income Loss
NetIncomeLoss
-1254043 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.011
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.002
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.024
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.006
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
251965750
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
203710642
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
240775933
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
200016816
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
736957 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000 USD
CY2021Q1 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
70264 USD
CY2021Q1 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4913200 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
62785 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
18723 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-438422 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4550732 USD
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
180000 USD
CY2021Q2 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
323310 USD
CY2021Q2 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2340723 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2788140 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4606625 USD
CY2021Q3 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2221223 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2671905 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4155943 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
680465 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
310303 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
53447 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-530307 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
813908 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
23692 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
191839 USD
CY2020Q2 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-289632 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
739807 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
31454 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
235296 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
73773 USD
CY2020Q3 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-434104 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
646226 USD
us-gaap Net Income Loss
NetIncomeLoss
-5898467 USD
us-gaap Net Income Loss
NetIncomeLoss
-1254043 USD
us-gaap Depreciation
Depreciation
0 USD
us-gaap Depreciation
Depreciation
126 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
60772 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
60172 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
73720 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
296738 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4580669 USD
us-gaap Share Based Compensation
ShareBasedCompensation
73773 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-52363 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
89579 USD
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-11750 USD
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-2315 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
308779 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-124161 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-810414 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1034659 USD
crtg Payments For Website Costs
PaymentsForWebsiteCosts
12007 USD
crtg Payments For Website Costs
PaymentsForWebsiteCosts
-0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
90505 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
46986 USD
crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
334651 USD
crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
1047151 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4913200 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5157346 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000165 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4334925 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34494 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22219 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58149 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4357144 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23655 USD
us-gaap Interest Paid Net
InterestPaidNet
92434 USD
us-gaap Interest Paid Net
InterestPaidNet
50271 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
230000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300000 USD
crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
600 USD
crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
360 USD
crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
393574 USD
crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
0 USD
crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
0 USD
crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
737437 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
237344743
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57852957
CY2021Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1201034 USD
CY2020Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
266598 USD
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2190000
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0520
crtg Class Of Warrant Or Right Issued Monthly
ClassOfWarrantOrRightIssuedMonthly
88914000
crtg Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.0812
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
142604000
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0515
crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P4Y3M18D
CY2021Q3 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
7632862 USD
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6 pure
crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
5000000
crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
3000000
crtg Stock Cancelled And Reissued During Period
StockCancelledAndReissuedDuringPeriod
23000000
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.105
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
56173 USD
CY2021Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
53711609
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P4Y5M1D
CY2021Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
53211609
us-gaap Operating Lease Expense
OperatingLeaseExpense
11340 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
22134 USD
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
800 USD

Files In Submission

Name View Source Status
0001437749-21-025057-index-headers.html Edgar Link pending
0001437749-21-025057-index.html Edgar Link pending
0001437749-21-025057.txt Edgar Link pending
0001437749-21-025057-xbrl.zip Edgar Link pending
crtg-20210930.xsd Edgar Link pending
crtg-20210930_cal.xml Edgar Link unprocessable
crtg-20210930_def.xml Edgar Link unprocessable
crtg-20210930_lab.xml Edgar Link unprocessable
crtg-20210930_pre.xml Edgar Link unprocessable
crtg20210930_10q.htm Edgar Link pending
crtg20210930_10q_htm.xml Edgar Link completed
ex_300046.htm Edgar Link pending
ex_300047.htm Edgar Link pending
ex_300048.htm Edgar Link pending
ex_300049.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending